Note: Ingredients listed on restricted chemical lists
EC/CAS
148-79-8
Name of the chemical
2-Thiazol-4-yl-1H-benzoimidazole
Concentration
<5
General Information
Revision date
2015-01-08
Product name
TRESADERM DERMATOLOGICAL SOLUTION
Product name
TRESADERM DERMATOLOGICAL SOLUTION
Identification on the label/Trade name
TRESADERM TRESADERM DERMATOLOGICAL SOLUTION TRESADERM VET. LOSNING TRESADERM VET. SOLUTION and transport of the mixture. Professional and non-professional users package inserts for the proper use, storage and disposal of this mixture
Product Synonyms
Mixture
Chemical name
Mixture
1.2.1 Relevant identified uses
Tresaderm Dermatological Solution is used
Manufacturer Name
storage and transport
Emergency telephone
1-888-637-4251, 1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
storage and transport
Section 2
SECTION 2: Hazards identification
Emergency Overview Very toxic to aquatic life. Do not eat, drink, or smoke when handling this mixture. Wash hands thoroughly after handling.
Physical hazards
The mixture consists of ingredients that alone are classified as flammable. However, since the overall quantity of these ingredients is approximately 5% of the mixture, the mixture is not anticipated to be flammable.
Health hazards
Evaluation of potential acute or from the individual ingredients of the mixture did not trigger health hazards classifications of the mixture under the GHS classification system.
Environmental hazards
Evaluation of potential acute or chronic aquatic hazards from the individual ingredients of the mixture based upon computer modeling did not trigger environmental hazard classifications of the mixture under the GHS classification system.
Hazard statements
None Safety Phrase(s): S2 Keep Out Of The Reach Of Children
Potential health effects
The following potential human health effects are the results of the exposure to the mixture or extrapolated from the individual ingredients of the mixture. EYE: The product is not anticipated to be irritating to the eyes. SKIN: The product is not anticipated to produce skin irritation or sensitization. INHALATION: The mixture is not anticipated to produce vapors in a sufficient quantity that would be irritating to eyes, skin, nose and/or throat. INGESTION: The product is not anticipated to be harmful if swallowed.
Potential chronic health
The mixture is not anticipated to be carcinogenic, mutagenic, or a reproductive/developmental hazard. SIGNS AND SYMPTOMS OF No specific signs or symptoms of exposure are known. EXPOSURE
Medical Conditions Generally Aggravated by Exposure
None known.
